Listed

Q32 Bio Inc.

QTTBNasdaqCIK 1661998HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2024
Operating income−$9.1m, Q2 FY2026
Net income−$8.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2023-11-14, accession 0000950170-23-063667.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-13, accession 0000950170-24-030478. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-05-09, accession 0000950170-24-056273.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-08-08, accession 0000950170-24-093305.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m7.5Research and development, Q3 FY2023, three months to 2023-09-30$7.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figure8.3Research and development, Q4 FY2023, three months to 2023-12-31$8.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-11, accession 0000950170-25-036823. Derived: 12-month figure less the 9-month figure.Report this figure9.8Research and development, Q1 FY2024, three months to 2024-03-31$9.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figure13.4Research and development, Q2 FY2024, three months to 2024-06-30$13.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure14.3Research and development, Q3 FY2024, three months to 2024-09-30$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure10.5Research and development, Q4 FY2024, three months to 2024-12-31$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figure7.1Research and development, Q1 FY2025, three months to 2025-03-31$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure5.2Research and development, Q2 FY2025, three months to 2025-06-30$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure3.6Research and development, Q3 FY2025, three months to 2025-09-30$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure3.3Research and development, Q4 FY2025, three months to 2025-12-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figure3.2Research and development, Q1 FY2026, three months to 2026-03-31$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure4.3Research and development, Q2 FY2026, three months to 2026-06-30$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure
Operating income$m(7.8)Operating income, Q3 FY2023, three months to 2023-09-30−$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figure(25.8)Operating income, Q4 FY2023, three months to 2023-12-31−$25.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-11, accession 0000950170-25-036823. Derived: 12-month figure less the 9-month figure.Report this figure(14.8)Operating income, Q1 FY2024, three months to 2024-03-31−$14.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figure(17.9)Operating income, Q2 FY2024, three months to 2024-06-30−$17.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure(18.8)Operating income, Q3 FY2024, three months to 2024-09-30−$18.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure(14.5)Operating income, Q4 FY2024, three months to 2024-12-31−$14.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figure(12.2)Operating income, Q1 FY2025, three months to 2025-03-31−$12.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure(9.2)Operating income, Q2 FY2025, three months to 2025-06-30−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure(7.6)Operating income, Q3 FY2025, three months to 2025-09-30−$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure45.9Operating income, Q4 FY2025, three months to 2025-12-31$45.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figure(7.7)Operating income, Q1 FY2026, three months to 2026-03-31−$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure(9.1)Operating income, Q2 FY2026, three months to 2026-06-30−$9.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure
Income tax$m(0.1)Income tax, Q3 FY2023, three months to 2023-09-30−$65.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figure0.4Income tax, Q4 FY2023, three months to 2023-12-31$383.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-11, accession 0000950170-25-036823. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$21.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure
Net income$m(14.0)Net income, Q3 FY2023, three months to 2023-09-30−$14.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figure(27.1)Net income, Q4 FY2023, three months to 2023-12-31−$27.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-11, accession 0000950170-25-036823. Derived: 12-month figure less the 9-month figure.Report this figure1.0Net income, Q1 FY2024, three months to 2024-03-31$1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure(17.0)Net income, Q2 FY2024, three months to 2024-06-30−$17.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure(17.6)Net income, Q3 FY2024, three months to 2024-09-30−$17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure(14.2)Net income, Q4 FY2024, three months to 2024-12-31−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figure(11.0)Net income, Q1 FY2025, three months to 2025-03-31−$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure(9.5)Net income, Q2 FY2025, three months to 2025-06-30−$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure(7.4)Net income, Q3 FY2025, three months to 2025-09-30−$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure57.7Net income, Q4 FY2025, three months to 2025-12-31$57.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figure(7.6)Net income, Q1 FY2026, three months to 2026-03-31−$7.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure(8.9)Net income, Q2 FY2026, three months to 2026-06-30−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure
Diluted EPS$ per share(40.52)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$40.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figurenot reported(6.33)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$6.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figure(1.42)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure(1.46)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figurenot reported(0.90)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure(0.78)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure(0.60)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figurenot reported(0.54)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure(0.44)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure
Basic EPS$ per share(40.52)Basic EPS, Q3 FY2023, three months to 2023-09-30−$40.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figurenot reported1.03Basic EPS, Q1 FY2024, three months to 2024-03-31$1.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figure(1.42)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure(1.46)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figurenot reported(0.90)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.90 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure(0.78)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.78 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure(0.60)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figurenot reported(0.54)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure(0.44)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure

Balance sheet

Cash and equivalents$106.3m, Q2 FY2026
Shareholders' equity$105.9m, Q2 FY2026
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31period not labelled2025-05-19Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m25.6Cash and equivalents, FY2023, at 2023-12-31$25.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-11, accession 0000950170-25-036823.Report this figure116Cash and equivalents, Q1 FY2024, at 2024-03-31$115.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figure97.7Cash and equivalents, Q2 FY2024, at 2024-06-30$97.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure89.1Cash and equivalents, Q3 FY2024, at 2024-09-30$89.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure78.0Cash and equivalents, FY2024, at 2024-12-31$78.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001193125-26-099339.Report this figure65.5Cash and equivalents, Q1 FY2025, at 2025-03-31$65.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figurenot reported54.8Cash and equivalents, Q2 FY2025, at 2025-06-30$54.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure49.0Cash and equivalents, Q3 FY2025, at 2025-09-30$49.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure48.3Cash and equivalents, FY2025, at 2025-12-31$48.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure50.8Cash and equivalents, Q1 FY2026, at 2026-03-31$50.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure106Cash and equivalents, Q2 FY2026, at 2026-06-30$106.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure
Current assets$m28.7Current assets, FY2023, at 2023-12-31$28.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-11, accession 0000950170-25-036823.Report this figure138Current assets, Q1 FY2024, at 2024-03-31$138.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056273.Report this figure112Current assets, Q2 FY2024, at 2024-06-30$111.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093305.Report this figure93.9Current assets, Q3 FY2024, at 2024-09-30$93.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figure81.9Current assets, FY2024, at 2024-12-31$81.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099339.Report this figure68.6Current assets, Q1 FY2025, at 2025-03-31$68.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figurenot reported58.3Current assets, Q2 FY2025, at 2025-06-30$58.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure50.8Current assets, Q3 FY2025, at 2025-09-30$50.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure55.1Current assets, FY2025, at 2025-12-31$55.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure57.2Current assets, Q1 FY2026, at 2026-03-31$57.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure110Current assets, Q2 FY2026, at 2026-06-30$109.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure
Total assets$m47.1Total assets, FY2023, at 2023-12-31$47.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-11, accession 0000950170-25-036823.Report this figure152Total assets, Q1 FY2024, at 2024-03-31$152.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056273.Report this figure124Total assets, Q2 FY2024, at 2024-06-30$124.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093305.Report this figure105Total assets, Q3 FY2024, at 2024-09-30$104.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figure92.3Total assets, FY2024, at 2024-12-31$92.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-10, accession 0001193125-26-099339.Report this figure79.1Total assets, Q1 FY2025, at 2025-03-31$79.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figurenot reported66.1Total assets, Q2 FY2025, at 2025-06-30$66.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure57.8Total assets, Q3 FY2025, at 2025-09-30$57.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure61.8Total assets, FY2025, at 2025-12-31$61.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure63.7Total assets, Q1 FY2026, at 2026-03-31$63.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure116Total assets, Q2 FY2026, at 2026-06-30$115.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure
Current liabilities$m14.1Current liabilities, FY2023, at 2023-12-31$14.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-11, accession 0000950170-25-036823.Report this figure33.0Current liabilities, Q1 FY2024, at 2024-03-31$33.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056273.Report this figure17.2Current liabilities, Q2 FY2024, at 2024-06-30$17.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093305.Report this figure14.4Current liabilities, Q3 FY2024, at 2024-09-30$14.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figure16.5Current liabilities, FY2024, at 2024-12-31$16.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099339.Report this figure14.6Current liabilities, Q1 FY2025, at 2025-03-31$14.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figurenot reported11.5Current liabilities, Q2 FY2025, at 2025-06-30$11.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure11.1Current liabilities, Q3 FY2025, at 2025-09-30$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure11.3Current liabilities, FY2025, at 2025-12-31$11.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure10.7Current liabilities, Q1 FY2026, at 2026-03-31$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure5.4Current liabilities, Q2 FY2026, at 2026-06-30$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure
Total liabilities$m119Total liabilities, FY2023, at 2023-12-31$118.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-11, accession 0000950170-25-036823.Report this figure104Total liabilities, Q1 FY2024, at 2024-03-31$103.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056273.Report this figure90.7Total liabilities, Q2 FY2024, at 2024-06-30$90.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093305.Report this figure86.2Total liabilities, Q3 FY2024, at 2024-09-30$86.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figure86.7Total liabilities, FY2024, at 2024-12-31$86.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-10, accession 0001193125-26-099339.Report this figure83.1Total liabilities, Q1 FY2025, at 2025-03-31$83.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figurenot reported78.4Total liabilities, Q2 FY2025, at 2025-06-30$78.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure76.2Total liabilities, Q3 FY2025, at 2025-09-30$76.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure19.8Total liabilities, FY2025, at 2025-12-31$19.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure17.4Total liabilities, Q1 FY2026, at 2026-03-31$17.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure10.0Total liabilities, Q2 FY2026, at 2026-06-30$10.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure
Shareholders' equity$m(183)Shareholders' equity, FY2023, at 2023-12-31−$182.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001193125-26-099339.Report this figure48.8Shareholders' equity, Q1 FY2024, at 2024-03-31$48.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure33.5Shareholders' equity, Q2 FY2024, at 2024-06-30$33.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure18.3Shareholders' equity, Q3 FY2024, at 2024-09-30$18.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure5.7Shareholders' equity, FY2024, at 2024-12-31$5.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure(4.0)Shareholders' equity, Q1 FY2025, at 2025-03-31−$4.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure4.0Shareholders' equity, period not labelled, at 2025-05-19$4.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure(12.2)Shareholders' equity, Q2 FY2025, at 2025-06-30−$12.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure(18.4)Shareholders' equity, Q3 FY2025, at 2025-09-30−$18.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure42.0Shareholders' equity, FY2025, at 2025-12-31$42.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure46.3Shareholders' equity, Q1 FY2026, at 2026-03-31$46.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure106Shareholders' equity, Q2 FY2026, at 2026-06-30$105.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure

Cash flow

Operating cash flow−$3.1m, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m15.9Operating cash flow, Q3 FY2023, three months to 2023-09-30$15.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-122785. Derived: 9-month figure less the 6-month figure.Report this figure(10.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-11, accession 0000950170-25-036823. Derived: 12-month figure less the 9-month figure.Report this figure(14.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figure(22.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$22.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0000950170-25-103530. Derived: 6-month figure less the 3-month figure.Report this figure(19.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$19.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-278812. Derived: 9-month figure less the 6-month figure.Report this figure(11.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$11.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figure(12.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure(10.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333831. Derived: 6-month figure less the 3-month figure.Report this figure(4.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-278812. Derived: 9-month figure less the 6-month figure.Report this figure(6.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figure(6.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure(3.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333831. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-122785. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-11, accession 0000950170-25-036823. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-09, accession 0000950170-24-056273.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0000950170-25-103530. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$58.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-278812. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-278812. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001193125-26-099339. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)20.34m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares57.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3057,447,192 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0000950170-23-063667.Report this figure0.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31344,623 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056273.Report this figure0.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30347,936 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093305.Report this figure0.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30346,288 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-122785.Report this figure2.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-312,334,180 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066371.Report this figure12.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3011,964,224 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0000950170-25-103530.Report this figure12.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3012,076,412 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure12.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3112,197,615 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure12.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3012,197,615 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure12.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3012,240,542 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-278812.Report this figure14.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3114,095,371 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-205021.Report this figure20.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3020,342,345 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure

Shares outstanding: 29.77mShares outstanding, period not labelled, at 2026-08-0329,769,466 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333831.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.